CDNA
CDNA
NASDAQ · Biotechnology

Caredx Inc

$18.30
+0.46 (+2.58%)
As of Mar 25, 2:10 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 9 60%
Hold 6 40%
Sell 0 0%
Price Target
Analyst Price Target +172.2% upside
Low Target $29.15
Average Target $49.81
High Target $64.16
Current Price $18.30
Current
$18.30
Target
$49.81
$29.15 $49.81 avg $64.16
Scenario Analysis
Bear Case
$29.15
59.3%
Low target
Base Case
$49.81
+172.2%
Avg target
Bull Case
$64.16
+250.6%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$25.15
-27.2% from high
52-Week Low
$10.96
+67.0% from low
Target vs 52W High
$49.81
+98.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%